Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 161 citing articles:

Tumor-associated myeloid cells in cancer immunotherapy
Xinyu Cheng, Huilan Wang, Zhongyu Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 29
Natural Killer Cell-Based Immunotherapy against Glioblastoma
Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Maeoka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2111-2111
Open Access | Times Cited: 25
OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment
Shiyu Liu, Fan Li, Qiongqiong Ma, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4016-4029
Open Access | Times Cited: 24
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
Vrunda Trivedi, Changlin Yang, Kelena Klippel, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 15
Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages
Stoyan Tankov, Marija Petrovic, Marc Lecoultre, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 13
IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β–mediated immune suppression and potentiate anti-tumor responses in glioblastoma
Andrew J. Hou, Ryan M. Shih, Benjamin R. Uy, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1850-1866
Closed Access | Times Cited: 13
Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy
He Jiang, You Zhou, Lun‐Quan Sun
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Seethalakshmi Hariharan, Benjamin T. Whitfield, Christopher J. Pirozzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq
Daniel V. Brown, Casey J. A. Anttila, Ling Ling, et al.
Genomics (2024) Vol. 116, Iss. 2, pp. 110793-110793
Open Access | Times Cited: 9
Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactions
Sen Yang, Mengyi Wang, Yuze Hua, et al.
Cancer Letters (2024) Vol. 584, pp. 216610-216610
Closed Access | Times Cited: 9
Mechanistic insight into glioma through spatially multidimensional proteomics
Lei Shen, Zhourui Zhang, Pengfei Wu, et al.
Science Advances (2024) Vol. 10, Iss. 7
Open Access | Times Cited: 9
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population
Anthony Z. Wang, Bryce L. Mashimo, Maximilian O. Schaettler, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1106-1131
Closed Access | Times Cited: 9
Glioma-associated macrophages: unraveling their dual role in the microenvironment and therapeutic implications
Jiachen Wang, Shenglan Li, Yanjie Lan, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
Christopher Chang, Velina Chavarro, Jakob V. E. Gerstl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6733-6733
Open Access | Times Cited: 9
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
Tzu-Yi Chia, Leah K. Billingham, Lauren Boland, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Dendritic cell subsets and implications for cancer immunotherapy
Michael Y. Chen, Felicia Zhang, S. Peter Goedegebuure, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Neutrophil-based Trojan horse containing polymer nano-therapeutics for sono-activatable ferroptosis-immunotherapy of orthotopic glioma
Mengbin Ding, Anni Zhu, Yijing Zhang, et al.
Nano Today (2024) Vol. 57, pp. 102398-102398
Closed Access | Times Cited: 8
Overcoming immune evasion with innovative multi-target approaches for glioblastoma
Hai Su, Peng Yin, Yi‐Long Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Programs, origins and immunomodulatory functions of myeloid cells in glioma
Tyler E. Miller, Chadi El Farran, Charles P. Couturier, et al.
Nature (2025)
Open Access | Times Cited: 1
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
Georgina V. Long, Elena Shklovskaya, Laveniya Satgunaseelan, et al.
Nature Medicine (2025)
Open Access | Times Cited: 1
The Role of Myeloid Cells in GBM Immunosuppression
Ya-Jui Lin, Caren Yu-Ju Wu, Janet Y. Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Mapping and Validation of scRNA-Seq-Derived Cell-Cell Communication Networks in the Tumor Microenvironment
Kate Bridges, Kathryn Miller‐Jensen
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors
Lu Sun, Jenny C. Kienzler, Jeremy Reynoso, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 17
Open Access | Times Cited: 21
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Daoyuan Xie, Yaomei Tian, Die Hu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 18

Scroll to top